Introduction
Apoptosis is the most common mode of death under on the cell surface are of special interest from a growth regulatory point of view. Examples of such molecules physiological conditions, and is identified by morphological changes and condensation of nuclear chromatin, a process directly involved in induction of apoptosis are Fas/APO-1 (9,10) and the two tumor necrosis factor receptors (11, 12) . that is also accompanied by degradation of the nuclear DNA (1-4). The concept that apoptosis is an integrated
Another class of molecules that may mediate apoptosis in mammalian cells are receptors normally involved in the highly controlled process is now well documented (4,5). Recent studies indicate that apoptosis provides an important activation and stimulation of cell growth. Among these are: (i) the CD3-TCR complex, e.g. on immature thymocytes mechanism in the regulation of the immune system (6). Failure of cell death to progress may result in severe (13), and (ii) membrane-bound Ig on B lymphoma cells (14) and immature B cells (15). This so-called activationpathological conditions such as neoplasia (7) and autoimmunity (8). To understand the pathogenesis of cancer and induced apoptosis occurring at certain stages during lymphocyte development is generally believed to play an other diseases, it is therefore important to take into account the signals and mechanisms that regulate the death important role in the regulation of immune responses as well as in tolerance induction (16). External regulation of processes.
External death signals mediated through specific receptors apoptosis is also provided by survival signals mediated through cell surface molecules like CD20 and CD40, thus SDS-PAGE, as described (28) . For basic silver staining gels were sequentially fixed with: (i) 50% v/v methanol, 10% v/v rescuing the cells from apoptotic death that would otherwise occur (17). acetic acid; (ii) 50% methanol, 7% acetic acid for 30 min; (iii) 8.3% v/v glutaraldehyde for 30 min. The gels were washed MHC-I molecules are known to serve as restriction elements and recognition structures for CD8 ϩ T lymphocytes (18).
twice with water and then soaked in staining solution (0.4% w/v silver nitrate, 0.38% w/v sodium hydroxide, 1.4% ammoSeveral studies demonstrate that MHC-I molecules also have the capacity to transduce signals into the cell, thereby being nia). After extensive washing with water the bands were developed in 0.015% formaldehyde, 2.5% w/v sodium carbondirectly involved in the regulation of T and B cell activation (19) (20) (21) (22) (23) (24) (25) (26) (27) . Thus, the ligation of MHC-I molecules either with ate. The reaction was stopped using acetic acid (5% v/v). For amino acid sequencing, proteins were blotted onto immobilized CD8 (20), or with MHC-I reactive mAb (21,22), has been reported to trigger activation in normal resting T Immobilon PVDF membranes (Millipore, Bedford, MA) in a Trans-Blot Semi-Dry Transfer Cell (BioRad, Richmond, CA) and B cells. On the other hand, interactions between CD8 and the α3 domain of MHC-I have been shown to induce without prior fixation and staining. Proteins were extracted from the membrane and amino acid sequencing was perapoptosis in T cells that also receive a signal via the TCR (23).
We have investigated the capacity of BAL-1, here identified formed using Edman degradation on an ABI 477 Protein/ Peptide Sequencer (Perkin Elmer, Foster City, CA). as an anti-MHC-I mAb, to mediate apoptosis in various cells of hematopoietic origin. The results presented below show
Cell proliferation assay that cross-linking MHC-I molecules induces apoptotic death in human acute leukemic B cell lines, in myeloid precursor KM-3 cells (0.5ϫ10 6 cells/ml) were incubated for 2 h at 37°C in the presence of 3.5 µg/ml BAL-1 antibody before cell lines and in mature CD40-stimulated B cells. We suggest that signaling via MHC-I may have a function in growth the addition of cross-linking rabbit anti-mouse Ig antibody (Dako, Glostrup, Denmark; #Z259), at a final dilution of 1/60. regulation during B cell development.
After 44 h of incubation, the cells were pulsed with 1 µCi [methyl-3 H]thymidine (5.0 Ci/mmol; Amersham International, Methods Amersham, UK) for 4 h. Harvesting of cells and determination of radioactivity was performed as described (28) . Cell lines DNA extraction and agarose gel electrophoresis The cell lines used in this study were: KM-3 (human ALL, pre-B phenotype; kindly provided by Dr K. Nilsson, Uppsala, KM-3 cells (10 6 ) were cultured in the presence of apoptotic Sweden), HL-60 (human promyelocytic; ATCC, Rockville, MD)
antibodies and optimal amounts of cross-linking antibodies and the CD32-transfected mouse fibroblast cell line 162CG7 for 44 h and then washed with PBS. The cell pellet was (ATCC). All cell lines were cultured in RPMI 1640 (Northumbria resuspended in 200 µl of lysis solution (0.05 M EDTA, 0.1 M Biologicals, Cramlington, UK), supplemented with 4 mM Tris, pH 8.0, 0.1 M NaCl containing 1% SDS and 100 µg/ml L-glutamine, 1% v/v 100ϫnon-essential amino acids, 50 µg/ proteinase K) and incubated for 2 h at 37°C. After addition ml gentamicin and 10% FCS.
of 200 µl TE buffer (10 mM Tris, pH 8.0, 1 mM EDTA), the cell lysate was extracted sequentially with phenol, phenol:chloroAntibodies form (1:1) and chloroform. The DNA was then precipitated The mouse mAb BAL-1 (IgG2a) was derived from hybridoma by ethanol and dissolved in 50 µl TE buffer, containing RNase cells, as described elsewhere (28) . The hybridomas PA2.6, A (0.5 mg/ml). After incubation at 37°C for 2 h, the samples W6/32, BB7.5, BB7.7 and L368 producing antibodies against were mixed with 5 µl loading buffer (25% w/w Ficoll, 0.25% human MHC-I antigen were obtained from ATCC and cultured bromophenol blue) and analyzed by agarose (1.8%) gel according to the manufacturer's description. The anti-CD40 electrophoresis. The gel contained 0.1 µg/ml ethidium brommAb (S2C6) was a generous gift from Dr S. Paulie, Stockholm ide, and electrophoresis was carried out in a 40 mM TrisUniversity, Sweden. Antibodies were used as hybridoma acetate buffer (pH 8.0), containing 1 mM EDTA. supernatants or precipitated with ammonium sulfate before Colorimetric DNA fragmentation assay use in experiments. Where indicated, the precipitation step was followed by an affinity purification step, using Protein KM-3 cells (2ϫ10 6 ) were incubated for 42-48 h in the presence A-Sepharose (Sigma, St Louis, MO). Non-binding control of hybridoma supernatant and cross-linking antibody, as antibodies UPC10 (IgG2a) and MOPC (IgG1) were purchased described above. The degree of DNA fragmentation was from Sigma. The binding control antibody (anti-CD10, IgG2a) determined by the colorimetric method described by Sellins was obtained from Immunotech (Marseille, France).
and Cohen (29) . Briefly, antibody-treated cells were harvested and resuspended in 0.4 ml lysis buffer (10 mM Tris, 1 mM Identification of the antigen recognized by the BAL-1 antibody EDTA, 0.2% Triton X-100, pH 7.5). After 30 min on ice the lysate was centrifuged for 10 min at 13,000 g to separate Membranes from 5ϫ10 9 KM-3 cells were solubilized using sodium deoxycholate, as described previously (28) . For affinfragmented DNA in the cytoplasm from intact chromatin in the nucleus. DNA from pellet and supernatant was precipitity purification of antigen solubilized proteins were incubated with 100 µg BAL-1 antibody for 1 h at 4°C and then precipitated ated, using 12.5% TCA overnight at 4°C. After centrifugation as above, DNA samples were hydrolyzed in 80 µl 5% TCA at with Protein A-Sepharose. After extensive washing in 0.1 M Tris buffer, pH 8.0/0.1% sodium deoxycholate, the sample was 90°C for 10 min, followed by addition of 160 µl DPA reagent [0.15 g diphenylamine, 0.15 ml sulfuric acid, 0.05 ml acetaldeextracted by boiling in sample loading buffer and subjected to hyde (16 mg/ml stock) in 10 ml glacial acetic acid]. After
Stimulation of B cells with staphylococcal enterotoxin A (SEA) SEA incubation overnight at room temperature, the DNA content of the samples was determined in a microtiter plate reader Purified (CD19 ϩ ) B cells (2ϫ10 6 cells/ml, Ͼ95% purity) were (Molecular Devices, Menlo Park, CA) at 595 nm.
cultured in the presence of syngeneic irradiated (1500 rad) T cells (5ϫ10 5 cells/ml) and SEA (0.5 ng/ml) (Toxin TechnoBiotinylation of antibodies logy, Madison, WI) for 96 h. Cellular activation was verified Affinity purified BAL-1 antibodies (0.95 mg in 1.1 ml 0.1 M by measuring the [ 3 H]thymidine uptake and by staining sodium borate buffer, pH 8.8) was incubated with 95 µg with fluorochrome-labeled mAb against CD25 and CD38 as biotin-NHS (BioRad) for 4 h at room temperature. The reaction described. was stopped by the addition of 5 µl 1 M ammonium chloride and the sample was incubated for another 10 min before Stimulation of T cells with SEA extensive dialysis against PBS.
T cells were isolated from human PBMC preparations using AET-treated sheep red blood cells as described (33) . The Cross-blocking experiments purity of T cells was Ͼ95% as determined by flow cytometric KM-3 cells (2ϫ10 5 ) were pre-incubated with 1.3 µg of unlaanalysis of cells stained with PE-labeled anti-CD3 mAb beled anti-MHC-I mAb in 100 µl of PBS/0.1% BSA for 30 min (Becton Dickinson). Purified T cells (1.5ϫ10 6 cells/ml) were on ice. Then, 0.2 µg of biotinylated BAL-1 mAb was added stimulated for 48 h with SEA (1 ng/ml) in the presence of and the incubation continued for another 30 min. FITC-labeled irradiated (1500 rad) non-T cells (1.5ϫ10 5 cells/ml). Cellular streptavidin (Dako) was used to detect binding of biotinylated activation was verified by measuring [ 3 H]thymidine incorporaantibody to the cells. The fluorescence of individual cells was tion and by staining with fluorochrome-labeled mAb against measured using a FACScan flow cytometer equipped with CD25 and CD38 for analysis by flow cytometry. Lysys II software (Becton Dickinson, San Jose, CA). The cytometer was calibrated by eye using particles supplied by Cell cycle analysis of apoptotic and viable cells the manufacturer. Gates were set to exclude particles of Flow cytometric identification of apoptotic cells in relation to subcellular size as defined by forward and side scatter cell cycle position was performed using the in situ terminal measurements.
deoxynucleotidyl transferase assay, as described (34) . Briefly, cells (~2ϫ10 6 ) from control and anti-MHC-I treated cultures Infection of lymphocytes with Epstein-Barr virus (EBV) were fixed in 1% formaldehyde (15 min on ice), washed and EBV transformation of lymphocytes obtained from healthy permeabilized using 70% ethanol (-20°C). After washing in donors was performed as described previously (30) . Infected PBS the cells were incubated at 37°C for 30 min with 10 cells were seeded in cell culture flasks at a cell density of units of terminal deoxynucleotidyl transferase (Boehringer 2ϫ10 6 cells/ml together with irradiated (3000 rad) feeder cells Mannheim) and 0.5 nmol biotinylated dUTP (Boehringer [2ϫ10 5 peripheral blood mononuclear cells (PBMC)/ml] and Mannheim) in 50 µl of a potassium cacodylate buffer supplied incubated at 37°C for 6 weeks to establish transformants.
with the enzyme. The cells were then washed and stained for 30 min at room temperature with FITC-labeled avidin (Dako) CD40 activation of B cells diluted 1:50 in 4ϫSSC (35) , 0.1% Triton X-100 and 5% (w/v) PBMC were isolated from buffy coats of healthy donors by non-fat dry milk. After washing and treatment with 0.1% RNase density centrifugation on Ficoll-Paque (Pharmacia Biotech, A (Sigma) in PBS, propidium iodide (Sigma) was added to a Uppsala, Sweden). Subsequently, B cells were purified from final concentration of 5 µg/ml. The samples were analyzed in PBMC preparations using PAN B (anti-CD19-coated) maga FACScan flow cytometer equipped with Lysys II software. netic beads (Dynal, Oslo, Norway) as described (31) followed
The cytometer was calibrated by eye using particles supplied by addition of Detachabeads (Dynal) to separate cells from by the manufacturer. Gates were set to exclude cell aggregmagnetic beads. B lymphocytes were then cultured in the ates, and particles of subcellular size as defined by forward CD40 system, as described (32) . Briefly, purified (CD19 ϩ ) B and light scatter measurements. cells (5ϫ10 5 /ml) were cultured for 5-6 days in the presence of irradiated (7000 rad) 162CG7 cells (6ϫ10 4 /ml), anti-CD40 Results mAb (0.5 µg/ml) and rIL-4 (70 U/ml) (Genzyme, Cambridge, MA). Cellular activation was confirmed by staining with FITC-
The BAL-1 mAb identifies the MHC class I antigen labeled anti-CD19 mAb (Dako) in combination with phycoerythrin (PE)-conjugated mAb to CD25 and CD38 (Becton The BAL-1 mAb was previously shown to induce apoptosis when cross-linked on the surface of pre-B cell lines and proDickinson) respectively. Fluorescence intensity was analyzed on a FACScan flow cytometer. B cell purity was always Ͼ95%.
myelocytic cell lines (28) . To determine the specificity of BAL-1, the antibody was used to precipitate antigen from a Activation of B cells with Staphylococcus aureus Cowan membrane preparation of KM-3 cells. After SDS-12% PAGE I (SAC) one strong 44 kDa band was detected (Fig. 1) . At high polyacrylamide concentrations (15%) an additional 14 kDa Purified (CD19 ϩ ) B cells (5ϫ10 5 cells/ml) were cultured in supplemented RPMI (10 % FCS) in the presence of SAC band was also evident (data not shown). Proteins were blotted onto PVDF membranes and the 44 kDa band was cut out for suspension (Sigma) at a final dilution of 1 µl/ml for 36 h. Cellular activation was verified by measuring [ 3 H]thymidine N-terminal amino acid sequencing. The first 25 amino acids showed (100%) sequence identity with the HLA-A, -B, -C incorporation, as described above. microglobulin. Previously, a target protein with a slightly lower molecular weight (37 kDa) than that of the MHC-I heavy chain was identified using the BAL-1 antibody in Western blotting (28) . The reason for this discrepancy is not known and is under investigation.
Anti-MHC-I inhibits growth and induces DNA fragmentation in KM-3 cells
It was shown earlier that cross-linking of BAL-1 antibodies on the cell surface of KM-3 cells (ALL, pre-B cell phenotype) inhibits cell growth and induces fragmentation of DNA with a DNA ladder characteristic of apoptosis (28) . A panel of commercially available antibodies against monomorphic antibody reacts with an antigenic determinant common for HLA-A, -B, -C and β 2 -microglobulin (36) . The effect of different antibodies on thymidine uptake in KM-3 cells, after crosslinking with different amounts of rabbit anti-mouse Ig, is shown in Fig. 2 . All anti-MHC-I antibodies reduced the proliferation not shown), demonstrating that the apoptotic effect was not due to engagement of Fc receptors. rate significantly, although the optimal degree of cross-linking varied between the antibodies. The anti-CD10 antibody, that
In another experiment, the ability of different anti-MHC-I antibodies to block the binding of biotinylated BAL-1 antibodalso bound strongly to KM-3 cells (24) and was included as a binding control, did not affect the thymidine uptake. Growth ies to KM-3 cells was tested. Cells were pre-incubated on ice with excess unlabeled anti-MHC-I antibodies of different fine inhibition was always accompanied by DNA fragmentation characteristic of apoptotic death, as shown in Fig. 3 and specificities followed by incubation with biotinylated BAL-1. Blocking effects were assessed by flow cytometry. As shown Table 1 . In all cases, external cross-linking was required for induction of apoptosis. Isotype-matched, non-binding control in Fig. 4 none of the commercially available antibodies in the panel significantly blocked the binding of BAL-1 antibody, antibodies [UPC10 (28) and MOPC21 (data not shown)] did not affect the thymidine uptake significantly. In addition, indicating that BAL-1 recognizes a different epitope on the MHC-I molecule. In flow cytometric experiments BAL-1 was ligation of MHC-I using F(abЈ) 2 fragments of BAL-1 and RAM respectively, efficiently induced apoptosis in KM-3 cells (data found to bind strongly to 100% of the lymphocytes from KM-3 cells (2 ϫ 10 6 cells in a total volume of 6 ml) were cultured for 44 h in the presence of different anti-MHC-I antibodies (3.5 µg/ ml) and optimal amounts of rat anti-mouse Ig. DNA fragmentation was quantified using a colorimetric assay and results were expressed as the percentage fragmented DNA of the total DNA in the cells. Viable cells were counted using Trypan blue exclusion. Data represent mean values Ϯ SD for two different cultures. Ligation of MHC-I induces DNA fragmentation in anti-CD40-stimulated B cells.
The capacity of anti-MHC-I to induce apoptosis in mature peripheral B and T lymphocytes was also investigated. Thus, purified B or T cells were stimulated with appropriate stimuli for indicated periods of time and were then tested for susceptibility to MHC-I-mediated DNA fragmentation. The results are shown in Fig. 5 . Substantial, specific and reproducible DNA fragmentation was observed only in B cells stimulated through CD40, whereas no significant specific DNA fragmentation was seen in resting B or T cells, SEA-activated B or T cells or SAC-stimulated B cells. Generally, Ͼ80% of the stimulated lymphocytes expressed CD25 and CD38, except for the SEA-stimulated T cell cultures where only 45% of the cells expressed these activation markers. Thus, mature B cells were not generally susceptible to MHC-I-induced apoptosis, Due to the extended time course of the apoptotic response, killing might be expected to be cell cycle dependent. Cell cycle studies of dying cells were performed by combining several (Ͼ20) donors (data not shown), suggesting that BAL-1 recognizes a monomorphic determinant of MHC-I. Taken propidium iodide staining with in situ labeling of DNA strand breaks using terminal deoxynucleotidyl transferase (34) . By together, these results show that the apoptotic effect of anti-MHC-I is not dependent on interaction with a certain antigenic using this approach we could simultaneously identify apoptotic cells and relate their position in the cell cycle. The determinant. Rather, cross-linking, i.e. the ligation of cell surface molecules, was crucial.
promyelocytic cell line HL-60, previously found to be suscept-is increasing evidence that MHC-I can also mediate regulatory signals into the cell on which it is expressed, affecting cellular proliferation and activation (19) (20) (21) (22) (23) (24) (25) (26) (27) . The present studies show that antibody-mediated cross-linking of the MHC class I antigen induces apoptosis not only in human cells of an immature phenotype, such as pre-B cells and pro-myelocytic cells, but also in anti-CD40-stimulated mature B cells. Although this effect was independent of the epitope specificity of the anti-MHC-I antibodies, it was not observed in the absence of a cross-linker antibody, demonstrating that antigenic cross-linking is central to initiate apoptosis. This system is characterized by rather slow kinetics and a lag phase of 12 h before onset of DNA fragmentation, although an increase in metabolic activity in KM-3 cells was observed within 20 min after addition of cross-linker (37). Thus, it is possible that cell death occurs following initial cellular activation, i.e. activation-induced apoptosis.
Several investigators have reported that cross-linking of MHC-I can stimulate activation of mature T cells (19, 20) , T leukemic cells (25) and also mature B cells (22). Another study reported an inhibitory effect of soluble anti-MHC-I antibodies on SAC-induced stimulation of mature B cells (38) . The inhibitory effect was only seen if the MHC-I molecules were engaged before the addition of SAC, thus suggesting that MHC-I mediates a negative signal to resting B cells that prevents subsequent cellular activation. A similar inhibitory effect has been observed on T cells after addition of soluble anti-MHC-I mAb (27) . Taken together, it is clear that engagement of MHC-I mediates various cellular responses such as activation, growth inhibition and apoptosis, depending on the cell type and other factors such as differentiation stage and co-stimulatory signals. Although the intracytoplasmatic domain of MHC-I possesses a few potential phosphorylation the apoptotic response, it is reasonable that the natural ligand in vivo is expressed on the surface of a cell and this molecule may thus be identical to CD8, the TCR or MHC-I binding cell surface molecules on NK cells (42) . Consequently, wellible to MHC-I-induced apoptosis (28) , was used for these experiments. Figure 6 shows the cell cycle distribution of defined microenvironments may exist in vivo where susceptible immature B cells are actively killed. One possible function viable and apoptotic cells measured at different incubation times. Interestingly, apoptotic cells were most frequently in may be to create barriers to emigration of immature cells from the natural environment in the bone marrow into the circulation. the G 2 /M phase of the cell cycle, indicating that the cells died at a time point after the duplication of genetic material but Of malignant B cell lines, only poorly differentiated ALLs of pre-B cell phenotype including KM-3, Reh (28) and Nalm6 before cell division occurred. Consequently, a prerequisite for MHC-I-induced apoptosis is that the cells are proliferating (data not shown) have been found sensitive to BAL-1-induced apoptosis, whereas more differentiated lymphomas (BJAB, or are induced to proliferate as a consequence of MHC-I ligation.
Raji and CESS) appeared refractory to MHC-I cross-linking in this system (28) . These results imply a role of MHCSignificant apoptosis was first observed after 12 h of incubation, which was in agreement with earlier observa-I-mediated signals in controlling the growth of immature lymphocytes and, thus, possibly also in the oncogenesis tions (37) .
of ALL. A previous report describes the induction of apoptosis by Discussion signaling through MHC-I in normal T cell precursors that have also received a signal through the TCR (23). These MHC-I is most well known for its ability to present endogenously produced antigens to specific T cells. 
